Regulus Therapeutics Inc.

Rachunek Zysków i Strat


Profil spółki
Statystyki
Dywidendy
Rekomendacje
Wyceny
Wskaźniki
Analiza techniczna



Przychody TTM (mln): 0
EBIT TTM (mln): -41
index 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14
Rok finansowy 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Przychód (mln) 9 14 13 20 8 21 1 0 0 7 10 0 0 0 0
Przychód Δ r/r 0.0% 60.3% -7.9% 54.1% -60.8% 170.7% -94.2% -94.0% 0.0% 9388.9% 46.5% -100.0% 0.0% 0.0% 0.0%
Marża brutto 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 99.8% 99.8% -inf% -inf% -inf% 0.0%
EBIT (mln) -15 -7 -13 -18 -45 -55 -82 -70 -47 -17 -14 -28 -28 -31 -50
EBIT Δ r/r 0.0% -53.9% 76.2% 41.6% 152.3% 21.9% 48.8% -14.0% -33.3% -64.0% -15.9% 96.5% 1.5% 10.2% 60.9%
EBIT (%) -180.2% -51.8% -99.0% -91.0% -585.6% -263.8% -6826.0% -97404.2% -64948.6% -246.4% -141.5% 0.0% 0.0% 0.0% nan
Koszty finansowe (mln) 0 0 0 0 0 0 1 3 2 2 2 1 1 1 0
EBITDA (mln) -15 -6 -11 -17 -33 -54 -81 -68 -47 -17 -14 -28 -28 -31 -46
EBITDA(%) -171.3% -44.2% -90.1% -86.4% -432.1% -258.9% -6797.7% -94666.7% -64948.6% -246.4% -141.5% 0.0% 0.0% 0.0% nan
Podatek (mln) -0 0 -0 -0 0 -0 -0 -0 0 0 -0 0 0 0 0
Zysk Netto (mln) -16 -8 -17 -19 -57 -56 -82 -72 -49 -19 -15 -28 -28 -30 -46
Zysk netto Δ r/r 0.0% -51.1% 129.0% 7.2% 203.6% -1.6% 46.8% -12.1% -32.3% -61.8% -17.9% 82.2% 1.9% 6.1% 54.3%
Zysk netto (%) -180.9% -55.1% -137.1% -95.4% -739.1% -268.5% -6853.9% -99868.1% -67651.4% -272.1% -152.5% 0.0% 0.0% 0.0% nan
EPS -7273.96 -3554.0 -254.37 -58.22 -154.27 -130.12 -185.94 -114.7 -55.87 -10.77 -4.36 -3.24 -1.86 -1.58 -0.82
EPS (rozwodnione) -7273.96 -3554.0 -254.37 -58.22 -154.27 -130.12 -185.94 -114.7 -55.87 -10.77 -4.36 -3.24 -1.86 -1.58 -0.82
Ilośc akcji (mln) 0 0 0 0 0 0 0 1 1 2 3 9 15 19 56
Ważona ilośc akcji (mln) 0 0 0 0 0 0 0 1 1 2 3 9 15 19 56
Waluta USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD